Expertise in
54
conditions

Dr. Andrew H. Kellum

Hematology
North Mississippi Medical Center Inc.
961 S Gloster St, 
Tupelo, MS 
Accepting New Patients
Offers Telehealth
Expertise in
54
conditions
North Mississippi Medical Center Inc.
961 S Gloster St, 
Tupelo, MS 

Overview

Andrew Kellum is a Hematologist practicing medicine in Tupelo, Mississippi.

Dr. Kellum is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Thrombocytopenia, Primary Lymphoma of the Brain, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 4 clinical trials. Dr. Kellum is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in MS

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO

Locations

North Mississippi Medical Center Inc.
961 S Gloster St, Tupelo, MS 38801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinoma, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Drug
Study Drugs: RRx-001, Cisplatin, Etoposide, Carboplatin, Irinotecan, Vinorelbine, Doxil, Gemcitabine, Taxane, Paclitaxel, Nab-Paclitaxel, Pemetrexed
Study Phase: Phase 2
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
A Randomized Phase III Trial of OSE2101 Compared With Chemotherapy (Docetaxel or Pemetrexed) in HLA-A2 Positive Patients With Advanced Non-Small Cell Lung Cancer With Progressive Disease After Immune Checkpoint Inhibitors
Enrollment Status: Terminated
Publish Date: February 02, 2024
Intervention Type: Drug, Biological
Study Drugs: OSE2101, Docetaxel, Pemetrexed
Study Phase: Phase 3
A Randomized Controlled, Open Label, Adaptive Phase-3 Trial to Evaluate Safety and Efficacy of EndoTAG-1+GEM vs GEM Alone in Patients With Measurable Locally Advanced/Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment
A Randomized Controlled, Open Label, Adaptive Phase-3 Trial to Evaluate Safety and Efficacy of EndoTAG-1+GEM vs GEM Alone in Patients With Measurable Locally Advanced/Metastatic Adenocarcinoma of the Pancreas Failed on FOLFIRINOX Treatment
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Drug
Study Drugs: EndoTAG-1, Gemcitabine
Study Phase: Phase 3
Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin
Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Etoposide and Carboplatin
Enrollment Status: Completed
Publish Date: August 21, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

10 Total Publications

DNA polymerase κ participates in early S-phase DNA replication in human cells.
DNA polymerase κ participates in early S-phase DNA replication in human cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 01, 2024
Similar Doctors
Expertise in
36
conditions
Dr. Jiahuai Tan
Hematology
Expertise in
36
conditions
Dr. Jiahuai Tan
Hematology
Referral may be required

North Mississippi Medical Center Inc.

961 S Gloster St, 
Tupelo, MS 
 (0.1 miles away)
662-844-9166
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jiahuai Tan is a Hematologist practicing medicine in Tupelo, Mississippi. Dr. Tan is highly rated in 36 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Thrombocytopenia, Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Tan is currently accepting new patients.

Expertise in
141
conditions
Dr. C M. Jones
Hematology Oncology | Hematology | Oncology
Expertise in
141
conditions
Dr. C M. Jones
Hematology Oncology | Hematology | Oncology
Referral may be required
Before you request

Baptist Cancer Center (Physicians)

200 State Highway 30 W, 
New Albany, MS 
 (25.2 miles away)
662-538-2535
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

C Jones is a Hematologist Oncology specialist and a Hematologist practicing medicine in New Albany, Mississippi. Dr. Jones is highly rated in 141 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Protein C Deficiency, Congenital Antithrombin 3 Deficiency, Hereditary Resistance to Anti-Vitamin K, and Bone Marrow Aspiration. Dr. Jones is currently accepting new patients.

Expertise in
48
conditions
Dr. John P. Whitecar
Hematology Oncology | Hematology | Oncology
Expertise in
48
conditions
Dr. John P. Whitecar
Hematology Oncology | Hematology | Oncology
Referral may be required
Before you request

Baptist Cancer Center-Golden Triangle Columbus Radiation Clinic

345 Baptist Blvd, 
Columbus,, MS 
 (52.0 miles away)
662-244-4673
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Whitecar is a Hematologist Oncology specialist and a Hematologist practicing medicine in Columbus,, Mississippi. Dr. Whitecar is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Colorectal Cancer, Familial Colorectal Cancer, Protein C Deficiency, and Bone Marrow Aspiration. Dr. Whitecar is currently accepting new patients.

Frequently Asked Questions about Dr. Andrew H. Kellum

How do I make an appointment with Dr. Andrew H. Kellum?

You can book an appointment with Dr. Andrew H. Kellum by calling their office at 662-844-9166. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andrew H. Kellum a top-rated expert for Large-Cell Immunoblastic Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andrew H. Kellum is classified as an Distinguished expert for Large-Cell Immunoblastic Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andrew H. Kellum specialize in?

While Dr. Andrew H. Kellum is a Hematology, they have specific expertise in Large-Cell Immunoblastic Lymphoma, Thrombocytopenia, and Primary Lymphoma of the Brain. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Andrew H. Kellum participate in research or clinical trials?

Yes. Dr. Andrew H. Kellum has published 10 articles and abstracts on conditions like Large-Cell Immunoblastic Lymphoma. You can view a list of Dr. Andrew H. Kellum's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andrew H. Kellum accept my insurance?

Dr. Andrew H. Kellum accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 662-844-9166 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kellum's expertise for a condition
ConditionClose
    View All 22 Distinguished Conditions
    View All 32 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile